Corporate & Securities

Public and private companies of all sizes across a variety of industries turn to Bass, Berry & Sims for counsel on a wide range of corporate matters, including mergers, acquisitions and dispositions, capital markets transactions, executive compensation issues, corporate governance and shareholder activism. We serve as primary corporate and securities counsel to more than 35 public companies and have assisted many more in a number of high-profile, high-stakes engagements.

Chambers USA researchers have concluded that our corporate team is a “Preeminent group highly recommended for its expertise in big-ticket M&A transactions, including a significant amount of cross-border matters. Also has a wealth of experience advising on private offerings and shareholder activism issues. Maintains an enviable reputation for its work in major healthcare deals and also highly regarded for its work in the energy, technology, retail and financial services spheres. Additionally, the firm has extensive expertise in advising public companies and their executive boards on sophisticated corporate and securities matters, with further noteworthy expertise in private equity.” (from Chambers USA 2020) During the Chambers research process, one client admired the group for being “very knowledgeable, thorough and very conscious of what we need them to do – and they manage their priorities very well” while another source appreciated that the team “provides a New York level of expertise and skill, but at smaller market rates, which is really valuable.” (from Chambers USA 2020) Previous editions of Chambers reported “Their commitment is second to none” and “They go toe to toe on expertise with New York firms.” (from Chambers USA 2018) and “The firm’s performance was outstanding. I’d put them up there with the big firms globally – some of the finest attorneys I’ve seen.” (from Chambers USA 2015) Chambers ranked us in the highest tier in Corporate/M&A in the state of Tennessee for 18 consecutive years, with 10 of our corporate lawyers receiving individual rankings in 2020.

Our Corporate & Securities attorneys are leaders in industry organizations and have been recognized for their significant contributions to clients and for their accomplishments. One of our partners is a past Chair of the 4,000-member American Bar Association (ABA) Business Law Section Mergers and Acquisitions Committee, and other members of our group have led numerous committees, subcommittees and task forces within the ABA’s Business Law Section. In addition, more than 20 attorneys were recognized in corporate categories in Best Lawyers in America® 2019 and Corporate Board Member has ranked us for 11 consecutive years as the #1 corporate law firm in the Nashville metropolitan area.

  • Representation of LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management company focused on delivering services to managed care organizations and governmental entities throughout the United States, as well as the extension of its revolving credit facilities from $200 million to $225 million

    We represented LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management...
    Read More
    Client Type: Private Company
  • Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its sale of Hospice Partners of Kansas, LLC to Three Oaks Hospice, Inc.

    We represented Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in...
    Read More
    Client Type: Public Company
  • Representation of OneOncology, a community oncology practice management company, in its acquisition of University Oncology Hematology Associates, an oncology practice affiliated with Erlanger hospitals

    We represented OneOncology, a community oncology practice management company, in its acquisition of University Oncology Hematology Associates, an oncology practice...
    Read More
    Client Type: Private Company
  • Representation of Altamont Capital’s portfolio company, Sequel Youth & Family Services, in its acquisition of Pine Cone Therapies, a behavioral healthcare provider with treatment programs to assist those with Autism spectrum, speech-language, intellectual delay, neurological, and attention deficit disorders.

    We represented Altamont Capital’s portfolio company, Sequel Youth & Family Services, in its acquisition of Pine Cone Therapies, a behavioral...
    Read More
    Client Type: Private Company
  • Representation of BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital

    We represented BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital. BRC...
    Read More
    Client Type: Private Company
  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Read More
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Read More
    Client Type: Private Company
  • Representation of Lincare Holdings, Inc., a nationwide healthcare services organization and a Florida-based subsidiary of German multinational chemical company Linde AG, in its sale of their home infusion assets to KabaFusion, a provider of specialty acute and chronic home infusion therapies

    We represented Lincare Holdings, Inc., a nationwide healthcare services organization and a Florida-based subsidiary of German multinational chemical company Linde...
    Read More
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Read More
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Read More
    Client Type: Private Company
Marc E. Ackerman
Counsel
John R. Adgent
Associate
Shayan A. Ahmed
Associate
Martha B. Allard
Counsel
Richard W. Arnholt
Member
Taylor J. Ashley
Member
Wilmoth H. Baker, IV
Associate
Jaime L. Barwig
Member
Gardner B. Bell
Associate
Scott W. Bell
Member
Nicholas M. Bessette
Associate
Susan K. Bilbro
Counsel
Robert L. Brewer
Member
Al Bright, Jr.
Member
Laura R. Brothers
Member
Emily A. Burrows
Associate
Curtis Capeling
Member
James H. Cheek, III
Member
Stefanie Colletier
Associate
Meredith Edwards Collins
Associate
Bo R. Cook
Associate
Elizabeth  A. Cook
Associate
David Cox
Member
Alexandria Wood Davenport
Associate
J. Page Davidson
Member
K. Stewart Day
Associate
Ali Deatherage
Associate
Kevin H. Douglas
Member
Kristin C. Dunavant
Counsel
R. Todd Ervin
Member
Greg Everett
Associate
Curtis L. Fisher
Member
D. Lee Flaherty
Associate
Lara A. Flatau
Member
John L. Fuller
Member
Harry L. Goldsmith
Senior Advisor
B. Riney Green
Member
Sarah E. Guthrie
Associate
Mary Lindsey Hannahan
Associate
Andrew Hard
Associate
Chelsea L. Harrison
Associate
Brad L. Hart
Associate
Jonathan T. Hasebe
Senior Corporate Attorney
Grant Hauss
Associate
Michael R. Hill
Member
S. Ryan Hoffman
Member
Johnathan D. Holbrook
Associate
D. Scott Holley
Member
Michael J. Holley
Member
Lauren B. Huddleston
Associate
Angela Humphreys
Member
Tyler Huseman
Associate
J. Patrick Huston
Associate
Chris Johnson
Associate
Kris Kemp
Member
Jay H. Knight
Member
Eric J. Knox
Member
Michael R. Kuffner
Member
Howard H. Lamar III
Member
Robins H. Ledyard
Member
Philip M. Lewis
Member
James R. Litzow
Associate
Mark Manner
Member
David W. Marshburn
Associate
George H. Masterson
Member
Richard F. Mattern
Member
R. Davis Mello
Associate
Bryan W. Metcalf
Member
Lori B. Morgan
Member
Jennifer H. Noonan
Member
Jason Northcutt
Member
Andrea N. Orr
Member
J. Allen Overby
Member
Todd R. Overman
Member
Janice Parmar
Senior Healthcare Attorney
Tatjana Paterno
Member
Oliver H. Peglow
Attorney
Sarah M. Pelham
Associate
Frank M. Pellegrino
Member
Dillon Reid
Associate
Whitney Robinson
Associate
Todd J. Rolapp
Managing Partner
Sehrish Siddiqui
Member
Susan V. Sidwell
Member
Brian L. Sims
Member
J. Paul Singleton
Associate
Jonathan D. Stanley
Member
Greg Stevens
Senior Counsel
W. Benjamin Tarpley
Associate
T. Stephen C. Taylor
Member
G. Scott Thomas
Member
Oscar L. Thomas
Counsel
Shelley R. Thomas
Member
Rodrigo N. Valle
Associate
Timothy Van Hal
Associate
Sara Vance
Associate
David R. Venturella
Associate
Kurt Vincent
Associate
Tyler H. Wadlington
Associate
F. Mitchell Walker, Jr.
Member
Julie C. Walker
Senior Corporate Attorney
Leigh Walton
Member
Brian K. Wilke
Associate
Price W. Wilson
Member
Taylor K. Wirth
Associate
Lora A. Wuerdeman
Associate